Mutation Screening in Breast Cancer Genes
Author Information
Author(s): Mikko Vuorela, Katri Pylkäs, Robert Winqvist
Primary Institution: University of Oulu, Oulu University Hospital
Hypothesis
Do mutations in RNF8, UBC13, and MMS2 contribute to breast cancer susceptibility in Northern Finnish families?
Conclusion
Mutations in RNF8, UBC13, and MMS2 genes are unlikely to significantly contribute to breast cancer predisposition in Northern Finland.
Supporting Evidence
- The study screened 123 breast cancer families for mutations in three genes.
- No significant mutations were found in RNF8, UBC13, or MMS2.
- Previous studies suggested these genes might be involved in breast cancer, but this study found no evidence.
Takeaway
The study looked for changes in certain genes that might cause breast cancer in families, but didn't find any important mutations.
Methodology
The coding regions and splice junctions of RNF8, UBC13, and MMS2 were screened for mutations using various genetic analysis techniques.
Limitations
The study may not account for rare mutations outside the coding regions of the genes.
Participant Demographics
Affected index cases from 123 Northern Finnish breast cancer families, including high-risk and moderate-risk classifications.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website